# References

1. Farré-Maduell, E. & Casals-Pascual, C. The origins of gut microbiome research in Europe: From Escherich to Nissle. Hum. Microbiome J. 14, 100065 (2019).
2. Natividad, J. M. M. & Verdu, E. F. Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications. Pharmacol. Res. 69, 42–51 (2013).
3. Sommer, F. & Bäckhed, F. The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 11, 227–238 (2013).
4. Belizário, J. E. & Faintuch, J. Microbiome and gut dysbiosis. In Metabolic Interaction in Infection, 459–476 (Springer, 2018).
5. Borody, T. J. & Khoruts, A. Fecal microbiota transplantation and emerging applications. Nat. Rev. Gastroenterol. Hepatol. 9, 88–96 (2012).
6. Singh, S. et al. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin. Gastroenterol. Hepatol. 9, 769–775 (2011).
7. Ananthakrishnan, A. N., Xavier, R. J. & Podolsky, D. K. Inflammatory Bowel Diseases: A Clinician’s Guide (Wiley, New York, 2017).
8. Manichanh, C., Borruel, N., Casellas, F. & Guarner, F. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9, 599–608 (2012).
9. Kirsner, J. B. Historical aspects of inflammatory bowel disease. J. Clin. gastroenterol. 10, 286–297 (1988).
10. Kaplan, G. G. The global burden of IBD: From 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 12, 720–727 (2015).
11. Xavier, R. J. & Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427–434 (2007).
12. Lees, C. W. & Satsangi, J. Genetics of inflammatory bowel disease: Implications for disease pathogenesis and natural history. Expert Rev. Gastroenterol. Hepatol. 3, 513–534 (2009).
13. Zhang, Y.-Z. & Li, Y.-Y. Inflammatory bowel disease: Pathogenesis. World J. Gastroenterol. WJG 20, 91 (2014).
14. Fiocchi, C. & Iliopoulos, D. IBD systems biology is here to stay. Inflamm. Bowel Dis. 27, 760–770 (2021).
15. De Souza, H. S. P., Fiocchi, C. & Iliopoulos, D. The IBD interactome: An integrated view of aetiology, pathogenesis and therapy. Nat. Rev. Gastroenterol. Hepatol. 14, 739–749 (2017).
16. Barabási, A.-L., Gulbahce, N. & Loscalzo, J. Network medicine: A network-based approach to human disease. Nat. Rev. Genet. 12, 56 (2011).
17. Faust, K. et al. Signatures of ecological processes in microbial community time series. Microbiome 6, 1–13 (2018).
18. Bucci, V. et al. MDSINE: Microbial Dynamical Systems INference Engine for microbiome time-series analyses. Genome Biol. 17, 1–17 (2016).
19. Coyte, K. Z. & Rakoff-Nahoum, S. Understanding competition and cooperation within the mammalian gut microbiome. Current Biol. 29, R538–R544 (2019).
20. Vernocchi, P. et al. Network analysis of gut microbiome and metabolome to discover microbiota-linked biomarkers in patients affected by non-small cell lung cancer. Int. J. Mol. Sci. 21, 8730 (2020).
21. Bauer, E. & Thiele, I. From network analysis to functional metabolic modeling of the human gut microbiota. MSystems 3, 00209–17 (2018).
22. Stein, R. R. et al. Ecological modeling from time-series inference: Insight into dynamics and stability of intestinal microbiota. PLoS Comput. Biol. 9, e1003388. https://doi.org/10.1371/journal.pcbi.1003388 (2013).
23. Chen, L. et al. Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity. Nat. Commun. 11, 1–12 (2020).
24. Friedman, J. & Alm, E. J. Inferring correlation networks from genomic survey data. PLoS Comput. Biol. 8(9), e1002687 (2012).
25. Weiss, S. et al. Correlation detection strategies in microbial data sets vary widely in sensitivity and precision. ISME J. 10, 1669–1681 (2016).
26. Karp, P. D. et al. The biocyc collection of microbial genomes and metabolic pathways. Brief. Bioinform. 20, 1085–1093 (2019).
27. Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucl. Acids Res. 42, D459–D471. https://doi.org/10.1093/nar/gkt1103 (2013).
28. Franzosa, E. A. et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat. Methods 15, 962–968 (2018).
29. Cao, Y., Shen, J. & Ran, Z. H. Association between Faecalibacterium prausnitzii reduction and inflammatory bowel disease: A meta-analysis and systematic review of the literature. Gastroenterol. Res. Pract. 2014 (2014).
30. Xi, M. et al. Effects of stachyose on intestinal microbiota and immunity in mice infected with enterotoxigenic Escherichia coli. J. Funct. Foods 64, 103689 (2020).
31. Zhou, Y. & Zhi, F. Lower level of bacteroides in the gut microbiota is associated with inflammatory bowel disease: A meta-analysis. BioMed. Res. Int. https://doi.org/10.1155/2016/5828959 (2016).
32. Rhodes, J. M. The role of Escherichia coli in inflammatory bowel disease. Gut 56, 610–612 (2007).
33. Schirmer, M., Garner, A., Vlamakis, H. & Xavier, R. J. Microbial genes and pathways in inflammatory bowel disease. Nat. Rev. Microbiol. 17, 497–511 (2019).
34. Keighley, M. R. et al. Influence of inflammatory bowel disease on intestinal microflora. Gut 19, 1099–1104 (1978).
35. Zhu, C. et al. Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis. Mol. Med. Rep. 17, 7567–7574 (2018).
36. Hoffmann, T. W. et al. Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. ISME J. 10, 460–477 (2016).
37. IBDMDB - Home | IBDMDB.
38. Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655–662. https://doi.org/10.1038/s41586-019-1237-9 (2019).
39. KneadData - The Huttenhower Lab.
40. McIver, L. J. et al. BioBakery: A meta’omic analysis environment. Bioinformatics 34, 1235–1237. https://doi.org/10.1093/bioinformatics/btx754 (2018).
41. Tieri, P. et al. Network inference and reconstruction in bioinformatics. In Encyclopedia of Bioinformatics and Computational Biology (2019).
42. MacMahon, M. & Garlaschelli, D. Community detection for correlation matrices. arXiv:1311.1924 (2013).
43. Nicolini, C., Forcellini, G., Minati, L. & Bifone, A. Scale-resolved analysis of brain functional connectivity networks with spectral entropy. NeuroImage 211, 116603 (2020).
44. Balassa, B. Trade liberalisation and “revealed’’ comparative advantage 1. Manch. Sch. 33, 99–123 (1965).
45. Bruno, M. BiCM: Python package for the computation of the Bipartite Configuration Model. (2020).
46. Squartini, T. & Garlaschelli, D. Analytical maximum-likelihood method to detect patterns in real networks. New J. Phys. 13, 83001 (2011).
47. Saracco, F., Di Clemente, R., Gabrielli, A. & Squartini, T. Randomizing bipartite networks: The case of the World Trade Web. Sci. Rep. 5, 1–18. https://doi.org/10.1038/srep10595 (2015).
48. Saracco, F. et al. Inferring monopartite projections of bipartite networks: An entropy-based approach. New J. Phys. 19, 53022 (2017).
49. Neal, Z. The backbone of bipartite projections: Inferring relationships from co-authorship, co-sponsorship, co-attendance and other co-behaviors. Soc. Netw. 39, 84–97 (2014).
50. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodol.) 57, 289–300 (1995).